BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/23/2026 11:05:46 AM | Browse: 20 | Download: 84
 |
Received |
|
2025-09-15 00:39 |
|
Peer-Review Started |
|
2025-09-15 00:39 |
|
First Decision by Editorial Office Director |
|
2025-10-11 05:39 |
|
Return for Revision |
|
2025-10-11 05:39 |
|
Revised |
|
2025-10-13 14:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-06 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-07 01:53 |
|
Articles in Press |
|
2026-01-07 01:53 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-31 07:14 |
|
Publish the Manuscript Online |
|
2026-04-23 11:05 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Minireviews |
| Article Title |
Interleukin-1 receptor antagonist autoantibodies in Still’s disease: Mechanistic insights and laboratory testing
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abdellatif Bouayad |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdellatif Bouayad, Associate Professor, MD, Department of Immunology, Mohammed First University, Faculty of Medicine and Pharmacy Oujda, 4867 Oujda l’Université, Oujda-Angad 4867, Oriental, Morocco. a.bouayad@ump.ac.ma |
| Key Words |
Still’s disease; Interleukin-1 receptor antagonist autoantibodies; Pathogenesis; Enzyme-linked immunosorbent; Isoelectric focusing; Western blot; Interleukin-1β signaling reporter cell assays |
| Core Tip |
Still’s disease is a rare, severe systemic inflammatory disorder characterized by elevated levels of neutralizing interleukin-1 receptor antagonist autoantibodies. Their induction is thought to result from a combination of host-related factors, such as human leukocyte antigen class II alleles, and interleukin-1 receptor antagonist intrinsic factors, including hyperphosphorylation. Despite frequent detection of these antibodies using immunoassays and functional cell-based assays, the lack of assay standardization limits their clinical utility. At present, their presence is best regarded as a marker of underlying immune dysregulation rather than a direct pathogenic driver. |
| Publish Date |
2026-04-23 11:05 |
| Citation |
Bouayad A. Interleukin-1 receptor antagonist autoantibodies in Still’s disease: Mechanistic insights and laboratory testing. World J Methodol 2026; 16(2): 114269 |
| URL |
https://www.wjgnet.com/2222-0682/full/v16/i2/114269.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v16.i2.114269 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
